Close
ACHEMA MIDDLE EAST 2026

Cancer Medicine Prices Jump 53% In Five Years In The U.S

According to new research by Katie Porter, U.S. Democratic Representative and a consumer bankruptcy law professor vying for re-election in California, the cost of...

Report Indicates UK £62bn Behind In Global R&D Investment

According to a recent data study by the Institute for Public Policy Research, the UK's share of worldwide research and development (R&D) spending has...

Once More, M&As In Biotechechnology Industry Are Thriving

Deals can be just as significant in the drug development industry as scientific advancements. Without mergers and acquisitions, many of today's most significant pharmaceuticals—from...

Ancient Viral DNA Guards Against Infections In Human Genome

According to new research, ancient infections that left viral DNA in human genomes act as antivirals to shield human cells from some modern viruses. A...

Omicron Subvariants Withstand Essential Antibody Treatments

The White House issued a warning this week that HIV patients, kidney transplant recipients, and other immunocompromised people are particularly susceptible to COVID this...

Research And Development In UK Falls Behind Other Nations

According to a new report by IPPR, the UK's percentage of worldwide research and development (R&D) spending has decreased by 5% since 2014. Even...

Prostate Cancer Screening Rates Lower With Advanced Cancers

According to data from the U.S. Department of Veterans Affairs (VA), a reduction in prostate cancer screening has been associated with a subsequent rise...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...